Literature DB >> 26957562

Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs).

Carlos Alfaro1, Alvaro Teijeira1, Carmen Oñate1, Guiomar Pérez1, Miguel F Sanmamed2, Maria Pilar Andueza2, Diego Alignani3, Sara Labiano4, Arantza Azpilikueta4, Alfonso Rodriguez-Paulete4, Saray Garasa4, Juan P Fusco2, Angela Aznar4, Susana Inogés2, Maria De Pizzol5, Marcello Allegretti5, Jose Medina-Echeverz4, Pedro Berraondo4, Jose L Perez-Gracia2, Ignacio Melero6.   

Abstract

PURPOSE: Myeloid-derived suppressor cells (MDSC) are considered an important T-cell immunosuppressive component in cancer-bearing hosts. The factors that attract these cells to the tumor microenvironment are poorly understood. IL8 (CXCL8) is a potent chemotactic factor for neutrophils and monocytes. EXPERIMENTAL
DESIGN: MDSC were characterized and sorted by multicolor flow cytometry on ficoll-gradient isolated blood leucokytes from healthy volunteers (n = 10) and advanced cancer patients (n = 28). In chemotaxis assays, sorted granulocytic and monocytic MDSC were tested in response to recombinant IL8, IL8 derived from cancer cell lines, and patient sera. Neutrophil extracellular traps (NETs) formation was assessed by confocal microscopy, fluorimetry, and time-lapse fluorescence confocal microscopy on short-term MDSC cultures.
RESULTS: IL8 chemoattracts both granulocytic (GrMDSC) and monocytic (MoMDSC) human MDSC. Monocytic but not granulocytic MDSC exerted a suppressor activity on the proliferation of autologous T cells isolated from the circulation of cancer patients. IL8 did not modify the T-cell suppressor activity of human MDSC. However, IL8 induced the formation of NETs in the GrMDSC subset.
CONCLUSIONS: IL8 derived from tumors contributes to the chemotactic recruitment of MDSC and to their functional control. Clin Cancer Res; 22(15); 3924-36. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26957562     DOI: 10.1158/1078-0432.CCR-15-2463

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  128 in total

Review 1.  To NET or not to NET:current opinions and state of the science regarding the formation of neutrophil extracellular traps.

Authors:  Sebastian Boeltz; Poorya Amini; Hans-Joachim Anders; Felipe Andrade; Rostyslav Bilyy; Simon Chatfield; Iwona Cichon; Danielle M Clancy; Jyaysi Desai; Tetiana Dumych; Nishant Dwivedi; Rachael Ann Gordon; Jonas Hahn; Andrés Hidalgo; Markus H Hoffmann; Mariana J Kaplan; Jason S Knight; Elzbieta Kolaczkowska; Paul Kubes; Moritz Leppkes; Angelo A Manfredi; Seamus J Martin; Christian Maueröder; Norma Maugeri; Ioannis Mitroulis; Luis E Munoz; Daigo Nakazawa; Indira Neeli; Victor Nizet; Elmar Pieterse; Marko Z Radic; Christiane Reinwald; Konstantinos Ritis; Patrizia Rovere-Querini; Michal Santocki; Christine Schauer; Georg Schett; Mark Jay Shlomchik; Hans-Uwe Simon; Panagiotis Skendros; Darko Stojkov; Peter Vandenabeele; Tom Vanden Berghe; Johan van der Vlag; Ljubomir Vitkov; Maren von Köckritz-Blickwede; Shida Yousefi; Alexander Zarbock; Martin Herrmann
Journal:  Cell Death Differ       Date:  2019-01-08       Impact factor: 15.828

2.  CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma.

Authors:  Timothy Chao; Emma E Furth; Robert H Vonderheide
Journal:  Cancer Immunol Res       Date:  2016-10-13       Impact factor: 11.151

3.  Aggregated neutrophil extracellular traps resolve inflammation by proteolysis of cytokines and chemokines and protection from antiproteases.

Authors:  Jonas Hahn; Christine Schauer; Christine Czegley; Lasse Kling; Lenka Petru; Benjamin Schmid; Daniela Weidner; Christiane Reinwald; Mona H C Biermann; Stefan Blunder; Jürgen Ernst; Adam Lesner; Tobias Bäuerle; Ralf Palmisano; Silke Christiansen; Martin Herrmann; Aline Bozec; Robert Gruber; Georg Schett; Markus H Hoffmann
Journal:  FASEB J       Date:  2018-08-21       Impact factor: 5.191

Review 4.  Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus.

Authors:  Anca Dorhoi; Leigh A Kotzé; Jay A Berzofsky; Yongjun Sui; Dmitry I Gabrilovich; Ankita Garg; Richard Hafner; Shabaana A Khader; Ulrich E Schaible; Stefan He Kaufmann; Gerhard Walzl; Manfred B Lutz; Robert N Mahon; Suzanne Ostrand-Rosenberg; William Bishai; Nelita du Plessis
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

5.  Pharmacological targeting of peptidylarginine deiminase 4 prevents cancer-associated kidney injury in mice.

Authors:  Jessica Cedervall; Anca Dragomir; Falk Saupe; Yanyu Zhang; Johan Ärnlöv; Erik Larsson; Anna Dimberg; Anders Larsson; Anna-Karin Olsson
Journal:  Oncoimmunology       Date:  2017-04-20       Impact factor: 8.110

Review 6.  Mechanisms and biomarkers of cancer-associated thrombosis.

Authors:  Ann S Kim; Alok A Khorana; Keith R McCrae
Journal:  Transl Res       Date:  2020-07-06       Impact factor: 7.012

7.  The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape.

Authors:  Madelon M E de Jong; Zoltán Kellermayer; Natalie Papazian; Sabrin Tahri; Davine Hofste Op Bruinink; Remco Hoogenboezem; Mathijs A Sanders; Pieter C van de Woestijne; P Koen Bos; Cyrus Khandanpour; Jessica Vermeulen; Philippe Moreau; Mark van Duin; Annemiek Broijl; Pieter Sonneveld; Tom Cupedo
Journal:  Nat Immunol       Date:  2021-05-20       Impact factor: 25.606

Review 8.  Epithelial-mesenchymal transition and inflammation at the site of the primary tumor.

Authors:  Charli Dominguez; Justin M David; Claudia Palena
Journal:  Semin Cancer Biol       Date:  2017-08-18       Impact factor: 15.707

9.  Inhibiting Notch1 enhances immunotherapy efficacy in melanoma by preventing Notch1 dependent immune suppressive properties.

Authors:  Hong Qiu; Patrick M Zmina; Alex Y Huang; David Askew; Barbara Bedogni
Journal:  Cancer Lett       Date:  2018-07-21       Impact factor: 8.679

10.  Infiltrating Myeloid Cells Exert Protumorigenic Actions via Neutrophil Elastase.

Authors:  Irina Lerman; Maria de la Luz Garcia-Hernandez; Javier Rangel-Moreno; Luis Chiriboga; Chunliu Pan; Kent L Nastiuk; John J Krolewski; Aritro Sen; Stephen R Hammes
Journal:  Mol Cancer Res       Date:  2017-05-16       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.